Literature DB >> 2569683

So-called intracranial germ cell tumours: personal experiences and a theory of their pathogenesis.

K Sano1, M Matsutani, T Seto.   

Abstract

We investigated 110 cases of intracranial germ cell tumours (up to the end of 1986), 56% of which showed monotypic histological patterns and 44% were shown to be mixed tumours. All these cases underwent surgery followed by radiation and/or chemotherapy. All cases of choriocarcinoma and embryonal carcinoma died within 2 yr: cases of endodermal sinus tumour also showed poor results (4 yr survival rate was 12.5%). Mature teratoma had a 5 yr survival rate (5YSR) and a 10 yr survival rate (10YSR) of 78.3% each: immature teratoma showed a 5YSR of 44.9%. Two-cell pattern tumours (PTC) showed a 5YSR of 85.8% and a 10YSR of 82.4%. They (PTC) can be divided into two groups (i) germinoma and (ii) pinealoma of pineal parenchyma origin (pineocytoma with lymphocytic infiltration) on the basis of the difference in the tumour cell-stroma relationship and also placental alkaline phosphatase stain. In the pineal region, 70% of PTC belonged to the category of pinealoma and in the suprasellar region, 92% of PTC were germinoma. Germinoma showed a 5YSR of 91.4% and a 10YSR of 91.4%, whereas those of the pinealoma were 78.2% and 68.4% respectively. This suggests that the biological characteristics of germinoma and pinealoma may be different. All these results may bring into question the validity of the germ cell theory, since germinoma, which should be the most undifferentiated according to the theory, was the most benign and choriocarcinoma and endodermal sinus tumour, which should be the most differentiated, were the most malignant in the follow-up study.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2569683     DOI: 10.1080/01616412.1989.11739874

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  16 in total

1.  Spontaneous regression of a residual pineal tumor after resection of a cerebellar vermian germinoma.

Authors:  T Fujimaki; K Mishima; A Asai; I Suzuki; T Kirino
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapy.

Authors:  P L Robertson; R C DaRosso; J C Allen
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

3.  A primary intrasellar mixed germ cell tumor with suprasellar extension.

Authors:  Joo Pyung Kim; Bong Jin Park; Young Jin Lim
Journal:  Childs Nerv Syst       Date:  2011-04-15       Impact factor: 1.475

4.  Multimodality therapy for CNS mixed malignant germ cell tumors (MMGCT): results of a phase II multi-institutional study.

Authors:  Patricia L Robertson; Regina Jakacki; Juliette Hukin; Joao Siffert; Jeffrey C Allen
Journal:  J Neurooncol       Date:  2014-04-04       Impact factor: 4.130

5.  Complete disappearance of giant intracranial germinoma after irradiation.

Authors:  N G Rainov; H J Holzhausen; W Burkert
Journal:  Neurosurg Rev       Date:  1995       Impact factor: 3.042

6.  Intracranial germ-cell tumours--treatment results and residuals.

Authors:  C Haupt; U Ancker; M Muller; H D Herrmann; F J Schulte
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

7.  Treatment and survival of primary intracranial germ cell tumors: a population-based study using SEER database.

Authors:  Steven Denyer; Abhiraj D Bhimani; Shashank N Patil; Andrew Mudreac; Mandana Behbahani; Ankit I Mehta
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-19       Impact factor: 4.553

8.  Pediatric primary central nervous system germ cell tumors of different prognosis groups show characteristic miRNome traits and chromosome copy number variations.

Authors:  Hsei-Wei Wang; Yu-Hsuan Wu; Jui-Yu Hsieh; Muh-Lii Liang; Meng-En Chao; Da-Jung Liu; Ming-Ta Hsu; Tai-Tong Wong
Journal:  BMC Genomics       Date:  2010-02-24       Impact factor: 3.969

9.  Improved outcome of central nervous system germ cell tumors: implications for the role of risk-adapted intensive chemotherapy.

Authors:  Keon Hee Yoo; Soo Hyun Lee; Jeehun Lee; Ki Woong Sung; Hye Lim Jung; Hong Hoe Koo; Do Hoon Lim; Jong Hyun Kim; Hyung Jin Shin
Journal:  J Korean Med Sci       Date:  2010-02-17       Impact factor: 2.153

Review 10.  Primary medulla oblongata germinoma: a case report and review of the literature.

Authors:  Pao-Sheng Yen; Andy Shau-bin Chou; Chi-Jen Chen; Shih-Ming Jung; Huo-Li Chuang; R Michael Scott
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.